Merav Darash‐Yahana

Hebrew University of Jerusalem — Israel

Medicine · Health Sciences

17h-index1.8kcitations29works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Myeloid Leukemia Treatments(10), Chronic Lymphocytic Leukemia Research(9), Multiple Myeloma Research and Treatments(5), RNA modifications and cancer(5), Metalloenzymes and iron-sulfur proteins(5)

Publications29 total

Erk1R84H is an oncoprotein that causes hepatocellular carcinoma in mice and imposes a rigorous negative feedback loop
Oncogene·2025· 1 citedOpen Access
Data from Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 2 from Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 2 from Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 1 from Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 1 from Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Data from Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Table 1 from Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Table 1 from Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
The balancing act of NEET proteins: Iron, ROS, calcium and metabolism
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research·2020· 68 cited
NEET Proteins: A New Link Between Iron Metabolism, Reactive Oxygen Species, and Cancer
Antioxidants and Redox Signaling·2018· 187 citedOpen Access
Structure of the human monomeric NEET protein MiNT and its role in regulating iron and reactive oxygen species in cancer cells
Proceedings of the National Academy of Sciences·2017· 79 citedOpen Access
Interactions between mitoNEET and NAF-1 in cells
PLoS ONE·2017· 53 citedOpen Access
Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters
Proceedings of the National Academy of Sciences·2016· 81 citedOpen Access
Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cells
Journal of Cell Science·2015· 59 citedOpen Access
Characterization of tumor infiltrating Natural Killer cell subset
Oncotarget·2015· 121 citedOpen Access
The Fe-S cluster-containing NEET proteins mitoNEET and NAF-1 as chemotherapeutic targets in breast cancer
Proceedings of the National Academy of Sciences·2015· 79 citedOpen Access
Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML <i>In Vitro</i> and <i>In Vivo</i>
Molecular Cancer Therapeutics·2014· 59 cited
Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML in Vitro and in Vivo
Blood·2012· 5 cited
EZH2 promotes a bi-lineage identity in basal-like breast cancer cells
Oncogene·2012· 37 cited
page 1 of 2Next →

Frequent Co-authors

Amnon Peled(15), Katia Beider(13), Eithan Galun(13), Arnon Nagler(12), Ori Wald(11), Hanna Wald(11), Orly Blaier(10), Maya Koren‐Michowitz(10), Michal Abraham(10), Orly Eizenberg(10), Rachel Nechushtai(9), Ron Mittler(7), Luhua Song(6), Patricia A. Jennings(6), José N. Onuchic(6), Eli Pikarsky(5), Ola Karmi(5), Fang Bai(4), Yang‐Sung Sohn(4), Sagi Tamir(4)